Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity

In many respects, heterogeneity is one of the most striking revelations and common manifestations of a stem cell origin of cancer. We observe heterogeneity in myriad mixed tumors including testicular, lung, and breast cancers. We recognize heterogeneity in diverse tumor subtypes in prostate and kidn...

Full description

Bibliographic Details
Main Authors: Shi-Ming Tu, Miao Zhang, Christopher G. Wood, Louis L. Pisters
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/16/4006
_version_ 1797524479813877760
author Shi-Ming Tu
Miao Zhang
Christopher G. Wood
Louis L. Pisters
author_facet Shi-Ming Tu
Miao Zhang
Christopher G. Wood
Louis L. Pisters
author_sort Shi-Ming Tu
collection DOAJ
description In many respects, heterogeneity is one of the most striking revelations and common manifestations of a stem cell origin of cancer. We observe heterogeneity in myriad mixed tumors including testicular, lung, and breast cancers. We recognize heterogeneity in diverse tumor subtypes in prostate and kidney cancers. From this perspective, we illustrate that one of the main stem-ness characteristics, i.e., the ability to differentiate into diverse and multiple lineages, is central to tumor heterogeneity. We postulate that cancer subtypes can be meaningless and useless without a proper theory about cancer’s stem cell versus genetic origin and nature. We propose a unified theory of cancer in which the same genetic abnormalities, epigenetic defects, and microenvironmental aberrations cause different effects and lead to different outcomes in a progenitor stem cell versus a mature progeny cell. We need to recognize that an all-encompassing genetic theory of cancer may be incomplete and obsolete. A stem cell theory of cancer provides greater universality, interconnectivity, and utility. Although genetic defects are pivotal, cellular context is paramount. When it concerns tumor heterogeneity, perhaps we need to revisit the conventional wisdom of precision medicine and revise our current practice of targeted therapy in cancer care.
first_indexed 2024-03-10T08:58:00Z
format Article
id doaj.art-f63dc9d801554ea5a0c58982f8f758d2
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T08:58:00Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-f63dc9d801554ea5a0c58982f8f758d22023-11-22T07:02:23ZengMDPI AGCancers2072-66942021-08-011316400610.3390/cancers13164006Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and PlasticityShi-Ming Tu0Miao Zhang1Christopher G. Wood2Louis L. Pisters3Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USAIn many respects, heterogeneity is one of the most striking revelations and common manifestations of a stem cell origin of cancer. We observe heterogeneity in myriad mixed tumors including testicular, lung, and breast cancers. We recognize heterogeneity in diverse tumor subtypes in prostate and kidney cancers. From this perspective, we illustrate that one of the main stem-ness characteristics, i.e., the ability to differentiate into diverse and multiple lineages, is central to tumor heterogeneity. We postulate that cancer subtypes can be meaningless and useless without a proper theory about cancer’s stem cell versus genetic origin and nature. We propose a unified theory of cancer in which the same genetic abnormalities, epigenetic defects, and microenvironmental aberrations cause different effects and lead to different outcomes in a progenitor stem cell versus a mature progeny cell. We need to recognize that an all-encompassing genetic theory of cancer may be incomplete and obsolete. A stem cell theory of cancer provides greater universality, interconnectivity, and utility. Although genetic defects are pivotal, cellular context is paramount. When it concerns tumor heterogeneity, perhaps we need to revisit the conventional wisdom of precision medicine and revise our current practice of targeted therapy in cancer care.https://www.mdpi.com/2072-6694/13/16/4006tumor heterogeneitycancer subtypescancer stem cellsunified theoryclonal originprecision medicine
spellingShingle Shi-Ming Tu
Miao Zhang
Christopher G. Wood
Louis L. Pisters
Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity
Cancers
tumor heterogeneity
cancer subtypes
cancer stem cells
unified theory
clonal origin
precision medicine
title Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity
title_full Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity
title_fullStr Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity
title_full_unstemmed Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity
title_short Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity
title_sort stem cell theory of cancer origin of tumor heterogeneity and plasticity
topic tumor heterogeneity
cancer subtypes
cancer stem cells
unified theory
clonal origin
precision medicine
url https://www.mdpi.com/2072-6694/13/16/4006
work_keys_str_mv AT shimingtu stemcelltheoryofcanceroriginoftumorheterogeneityandplasticity
AT miaozhang stemcelltheoryofcanceroriginoftumorheterogeneityandplasticity
AT christophergwood stemcelltheoryofcanceroriginoftumorheterogeneityandplasticity
AT louislpisters stemcelltheoryofcanceroriginoftumorheterogeneityandplasticity